Intelligent bio solutions adds logistics firm to fingerprint drug screening portfolio and completes major milestone with existing client

Vkvp haulage adopts fingerprint drug screening system to help drive proactive drug testing policy auctus management group successfully completes 25,000 tests using the company's intelligent fingerprinting drug screening system new york, oct. 05, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (“inbs” or the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the adoption of its intelligent fingerprinting drug screening system by specialist container logistics firm, vkvp haulage . additionally, the company announced the successful completion of 25,000 intelligent fingerprinting tests with its current customer, auctus management group.
INBS Ratings Summary
INBS Quant Ranking